Pharmaceutical companies seeking permission from different European Union member states to carry out human drug trials will have to use a new application form as of 7 September1,2.
The use of the new form will coincide with the release of the latest version of the EU clinical trials database (ie EudraCT Version 8...
Please login to read the full article.
